In the Matter of J&R Research Corp

The FTC alleged that the litany of claims J&R made in advertising the company's nutritional supplements were unsubstantiated by reliable and competent scientific evidence.


J&R Research and the FTC agreed that J&R would restrict the health claims advertised about J&R's products in exchange for the FTC withdrawing it's complaint against the company. J&R made a variety of claims that its products cured or treated a significant number of health problems, such as diabetes, arthritis, lupus, stroke, high blood pressure, and others. The FTC claimed that there existed no competent scientific evidence that supported the company's effectiveness claims. In settling the dispute, J&R agreed to no longer advertise certain enumerated health benefits without corresponding scientific support. Additionally, the company agreed to cease using customer testimonials that are not typical or ordinary without disclosing the generally expected results or the limited applicability of the endorser’s testimony.

The full case and case summary are also available online at:

LOADING PDF: If there are any problems, click here to download the file.

Published In: MLM / Direct Sales Updates, MLM Consulting / Network Marketing Updates

Reference Info:Federal, 8th Circuit, Iowa | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Babener & Associates | Attorney Advertising

Don't miss a thing! Build a custom news brief:

Read fresh new writing on compliance, cybersecurity, Dodd-Frank, whistleblowers, social media, hiring & firing, patent reform, the NLRB, Obamacare, the SEC…

…or whatever matters the most to you. Follow authors, firms, and topics on JD Supra.

Create your news brief now - it's free and easy »


Welcome to MLM Legal - a valuable resource to the Multi-Level Marketing and Direct Sales Industry. ... View Profile »

Follow Babener & Associates:

Reporters on Deadline